Symbols / HIMS Stock $30.56 +8.56% Hims & Hers Health, Inc.

Healthcare • Drug Manufacturers - Specialty & Generic • United States • NYQ
HIMS (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Mr. Andrew Dudum
Exch · Country NYQ · United States
Market Cap 6.97B
Enterprise Value 7.51B
Income 128.37M
Sales 2.35B
FCF (ttm) 110.51M
Book/sh 2.38
Cash/sh 2.53
Employees 2,442
Insider 10d —
IPO Sep 13, 2019
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 59.92
Forward P/E 22.16
PEG 2.63
P/S 2.97
P/B 12.84
P/C —
EV/EBITDA 42.75
EV/Sales 3.20
Quick Ratio 1.51
Current Ratio 1.90
Debt/Eq 207.16
LT Debt/Eq —
EPS (ttm) 0.51
EPS next Y 1.38
EPS Growth -17.40%
Revenue Growth 28.40%
EPS Gr Q/Q -20.80%
Rev Gr Q/Q —
Earnings (next) 2026-05-11
Earnings (prior) 2026-02-23
ROA 5.29%
ROE 25.23%
ROIC —
Gross Margin 73.83%
Oper. Margin 2.72%
Profit Margin 5.47%
Shs Outstand 219.56M
Shs Float 207.42M
Insider Own 5.47%
Instit Own 86.03%
Short Float 37.85%
Short Ratio 2.67
Short Interest 69.77M
52W High 70.43
vs 52W High -56.61%
52W Low 13.74
vs 52W Low 122.42%
Beta 2.31
Impl. Vol. 0.39%
Rel Volume 1.02
Avg Volume 39.79M
Volume 40.41M
Target (mean) $25.57
Tgt Median $24.50
Tgt Low $16.00
Tgt High $35.00
# Analysts 14
Recom Hold
Prev Close $28.15
Price $30.56
Change 8.56%
About

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. Hims & Hers Health, Inc. is based in San Francisco, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$25.57
Mean price target
2. Current target
$30.56
Latest analyst target
3. DCF / Fair value
$9.06
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$30.56
Low
$16.00
High
$35.00
Mean
$25.57

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-24 init JP Morgan — → Overweight $35
2026-04-24 main B of A Securities Neutral → Neutral $32
2026-04-16 main B of A Securities Neutral → Neutral $25
2026-03-27 main TD Cowen Hold → Hold $23
2026-03-16 main Leerink Partners Market Perform → Market Perform $25
2026-03-11 main Barclays Overweight → Overweight $29
2026-03-10 up Citigroup Sell → Neutral $24
2026-03-10 main Deutsche Bank Hold → Hold $28
2026-03-10 up B of A Securities Underperform → Neutral $23
2026-03-09 up Needham Hold → Buy $30
2026-02-25 main Barclays Overweight → Overweight $25
2026-02-25 main Morgan Stanley Equal-Weight → Equal-Weight $21
2026-02-24 main Leerink Partners Market Perform → Market Perform $18
2026-02-24 down BTIG Buy → Neutral —
2026-02-24 main Citigroup Sell → Sell $13
2026-02-24 main TD Cowen Hold → Hold $17
2026-02-24 reit Truist Securities Hold → Hold $18
2026-02-24 main Evercore ISI Group In-Line → In-Line $24
2026-02-09 main TD Cowen Hold → Hold $20
2026-02-09 main Citigroup Sell → Sell $17
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-20 BOUGHTON SOLEIL Officer — 9,463 $30.00 $283,890
2026-04-20 OKUPE OLUYEMI Chief Financial Officer — 19,645 $29.96 $588,615
2026-04-20 OKUPE OLUYEMI Chief Financial Officer — 12,553 $5.01 $108,531
2026-04-17 OKUPE OLUYEMI Chief Financial Officer — 54,927 $25.90 $1,457,305
2026-04-17 OKUPE OLUYEMI Chief Financial Officer — 6,184 $5.01 $30,982
2026-04-09 DUDUM ANDREW Chief Executive Officer — 422,933 $0.00 $0
2026-04-06 OKUPE OLUYEMI Chief Financial Officer — 3,975 $19.98 $79,409
2026-04-06 OKUPE OLUYEMI Chief Financial Officer — 3,975 $5.01 $19,915
2026-03-20 OKUPE OLUYEMI Chief Financial Officer — 9,217 $23.77 $219,067
2026-03-20 OKUPE OLUYEMI Chief Financial Officer — 4,489 $5.01 $22,490
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
2,347.64
+59.00%
1,476.51
+69.33%
872.00
+65.49%
526.92
Operating Revenue
2,347.64
+59.00%
1,476.51
+69.33%
872.00
+65.49%
526.92
Cost Of Revenue
614.26
+102.47%
303.38
+93.17%
157.05
+32.88%
118.19
Reconciled Cost Of Revenue
614.26
+102.47%
303.38
+93.17%
157.05
+32.88%
118.19
Gross Profit
1,733.38
+47.76%
1,173.13
+64.09%
714.95
+74.92%
408.72
Operating Expense
1,627.77
+46.48%
1,111.23
+49.28%
744.40
+55.92%
477.42
Research And Development
149.30
+89.42%
78.82
+63.43%
48.23
+64.95%
29.24
Selling General And Administration
1,192.02
+40.80%
846.61
+46.90%
576.32
+55.43%
370.78
Selling And Marketing Expense
919.30
+35.42%
678.84
+52.06%
446.44
+63.78%
272.59
General And Administrative Expense
272.72
+62.56%
167.77
+29.17%
129.88
+32.27%
98.19
Other Gand A
272.72
+62.56%
167.77
+29.17%
129.88
+32.27%
98.19
Other Operating Expenses
286.44
+54.17%
185.80
+55.02%
119.86
+54.85%
77.40
Total Expenses
2,242.02
+58.49%
1,414.61
+56.93%
901.45
+51.35%
595.61
Operating Income
105.61
+70.61%
61.90
+310.18%
-29.45
+57.13%
-68.70
Total Operating Income As Reported
105.61
+70.61%
61.90
+310.18%
-29.45
+57.13%
-68.70
EBITDA
160.12
+102.70%
78.99
+496.18%
-19.94
+67.43%
-61.22
Normalized EBITDA
155.68
+97.08%
78.99
+496.18%
-19.94
+67.43%
-61.22
Reconciled Depreciation
54.50
+218.95%
17.09
+79.59%
9.52
+27.31%
7.47
EBIT
105.61
+70.61%
61.90
+310.18%
-29.45
+57.13%
-68.70
Total Unusual Items
4.44
—
—
0.07
Total Unusual Items Excluding Goodwill
4.44
—
—
0.07
Net Income
128.37
+1.85%
126.04
+635.28%
-23.55
+64.15%
-65.68
Pretax Income
123.92
+72.81%
71.71
+432.44%
-21.57
+67.17%
-65.71
Net Non Operating Interest Income Expense
—
—
—
—
Interest Expense Non Operating
—
—
—
—
Net Interest Income
—
—
—
—
Interest Expense
—
—
—
—
Other Income Expense
18.31
+86.69%
9.81
+24.44%
7.88
+163.79%
2.99
Other Non Operating Income Expenses
13.87
+41.46%
9.81
+24.44%
7.88
+163.79%
2.99
Gain On Sale Of Security
4.44
—
—
0.07
Tax Provision
-4.44
+91.83%
-54.33
-2850.73%
1.98
+6470.97%
-0.03
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
+44391.53%
0.00
Tax Effect Of Unusual Items
0.93
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
128.37
+1.85%
126.04
+635.28%
-23.55
+64.15%
-65.68
Net Income From Continuing Operation Net Minority Interest
128.37
+1.85%
126.04
+635.28%
-23.55
+64.15%
-65.68
Net Income From Continuing And Discontinued Operation
128.37
+1.85%
126.04
+635.28%
-23.55
+64.15%
-65.68
Net Income Continuous Operations
128.37
+1.85%
126.04
+635.28%
-23.55
+64.15%
-65.68
Normalized Income
124.86
-0.93%
126.04
+635.28%
-23.55
+64.15%
-65.68
Net Income Common Stockholders
128.37
+1.85%
126.04
+635.28%
-23.55
+64.15%
-65.68
Diluted EPS
0.51
-3.77%
0.53
+581.82%
-0.11
+65.63%
-0.32
Basic EPS
0.57
-1.72%
0.58
+627.27%
-0.11
+65.63%
-0.32
Basic Average Shares
224.96
+4.18%
215.94
+3.15%
209.34
+2.36%
204.52
Diluted Average Shares
258.23
+9.05%
236.81
+13.12%
209.34
+2.36%
204.52
Diluted NI Availto Com Stockholders
128.37
+1.85%
126.04
+635.28%
-23.55
+64.15%
-65.68
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
2,154.70
+204.54%
707.54
+60.37%
441.19
+20.43%
366.34
Current Assets
767.64
+93.93%
395.83
+49.34%
265.05
+22.37%
216.59
Cash Cash Equivalents And Short Term Investments
577.49
+92.34%
300.25
+35.87%
220.98
+23.02%
179.62
Cash And Cash Equivalents
228.62
+3.64%
220.58
+128.20%
96.66
+106.67%
46.77
Other Short Term Investments
348.88
+337.92%
79.67
-35.92%
124.32
-6.42%
132.85
Receivables
32.15
+428.77%
6.08
-9.90%
6.75
+108.85%
3.23
Accounts Receivable
32.15
+428.77%
6.08
-9.90%
6.75
+108.85%
3.23
Inventory
80.13
+24.37%
64.43
+186.80%
22.46
+4.18%
21.56
Raw Materials
53.15
+81.09%
29.35
+305.22%
7.24
+42.44%
5.08
Finished Goods
26.98
-23.09%
35.08
+130.45%
15.22
-7.62%
16.48
Prepaid Assets
73.50
+197.88%
24.67
+131.35%
10.66
+2.63%
10.39
Current Deferred Assets
—
—
—
—
Other Current Assets
4.37
+993.50%
0.40
-90.46%
4.20
+135.01%
1.78
Total Non Current Assets
1,387.07
+344.99%
311.71
+76.97%
176.13
+17.62%
149.75
Net PPE
448.98
+382.96%
92.96
+103.28%
45.73
+183.43%
16.14
Gross PPE
501.56
+327.00%
117.46
+102.61%
57.98
+159.09%
22.38
Accumulated Depreciation
-52.59
-114.66%
-24.50
-100.09%
-12.24
-96.19%
-6.24
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
134.31
+117.03%
61.88
+98.20%
31.22
+99.48%
15.65
Other Properties
351.33
+686.94%
44.65
+82.26%
24.50
+272.94%
6.57
Leases
15.93
+45.66%
10.93
+384.62%
2.26
+1355.48%
0.15
Goodwill And Other Intangible Assets
474.44
+203.86%
156.14
+20.61%
129.46
-2.46%
132.72
Goodwill
278.32
+146.90%
112.73
+1.67%
110.88
+0.00%
110.88
Other Intangible Assets
196.12
+351.78%
43.41
+133.71%
18.57
-14.96%
21.84
Investments And Advances
351.26
0.00
—
—
Non Current Deferred Assets
82.71
+34.26%
61.60
0.00
—
Non Current Deferred Taxes Assets
82.71
+34.26%
61.60
0.00
—
Other Non Current Assets
29.68
+2859.12%
1.00
+5.91%
0.95
+6.52%
0.89
Total Liabilities Net Minority Interest
1,613.78
+599.14%
230.82
+137.58%
97.16
+77.94%
54.60
Current Liabilities
404.43
+82.70%
221.37
+150.22%
88.47
+84.54%
47.94
Payables And Accrued Expenses
268.78
+86.40%
144.19
+81.48%
79.45
+77.31%
44.81
Payables
199.90
+114.18%
93.33
+84.88%
50.48
+51.48%
33.33
Accounts Payable
143.28
+57.14%
91.18
+111.70%
43.07
+33.08%
32.36
Other Payable
46.99
—
7.41
—
Current Accrued Expenses
68.88
+35.43%
50.86
+75.55%
28.97
+152.26%
11.48
Total Tax Payable
9.64
+347.77%
2.15
+7.12%
2.01
+108.62%
0.96
Current Debt And Capital Lease Obligation
4.84
+156.38%
1.89
+47.46%
1.28
-22.74%
1.66
Current Capital Lease Obligation
4.84
+156.38%
1.89
+47.46%
1.28
-22.74%
1.66
Current Deferred Liabilities
127.16
+68.90%
75.28
+873.55%
7.73
+425.34%
1.47
Current Deferred Revenue
127.16
+68.90%
75.28
+873.55%
7.73
+425.34%
1.47
Other Current Liabilities
3.65
—
—
—
Total Non Current Liabilities Net Minority Interest
1,209.35
+12689.19%
9.46
+8.83%
8.69
+30.49%
6.66
Long Term Debt And Capital Lease Obligation
1,115.75
+11699.35%
9.46
+9.10%
8.67
+137.52%
3.65
Long Term Debt
972.58
—
—
—
Long Term Capital Lease Obligation
143.17
+1414.03%
9.46
+9.10%
8.67
+137.52%
3.65
Non Current Deferred Liabilities
28.86
0.00
—
—
Non Current Deferred Taxes Liabilities
28.86
0.00
—
—
Other Non Current Liabilities
64.74
—
0.02
-99.27%
3.01
Preferred Securities Outside Stock Equity
—
—
—
—
Stockholders Equity
540.93
+13.47%
476.72
+38.57%
344.03
+10.36%
311.74
Common Stock Equity
540.93
+13.47%
476.72
+38.57%
344.03
+10.36%
311.74
Capital Stock
0.02
+4.55%
0.02
+4.76%
0.02
+0.00%
0.02
Common Stock
0.02
+4.55%
0.02
+4.76%
0.02
+0.00%
0.02
Share Issued
227.25
+2.90%
220.84
+3.45%
213.48
+2.42%
208.43
Ordinary Shares Number
227.25
+2.90%
220.84
+3.45%
213.48
+2.42%
208.43
Additional Paid In Capital
652.38
-9.28%
719.15
+0.96%
712.31
+8.48%
656.63
Retained Earnings
-113.77
+53.01%
-242.14
+34.23%
-368.18
-6.83%
-344.63
Gains Losses Not Affecting Retained Earnings
2.29
+808.02%
-0.32
-161.29%
-0.12
+55.23%
-0.28
Other Equity Adjustments
2.29
+808.02%
-0.32
-161.29%
-0.12
+55.23%
-0.28
Total Equity Gross Minority Interest
540.93
+13.47%
476.72
+38.57%
344.03
+10.36%
311.74
Total Capitalization
1,513.51
+217.49%
476.72
+38.57%
344.03
+10.36%
311.74
Working Capital
363.21
+108.18%
174.46
-1.20%
176.59
+4.70%
168.65
Invested Capital
1,513.51
+217.49%
476.72
+38.57%
344.03
+10.36%
311.74
Total Debt
1,120.59
+9777.39%
11.35
+14.04%
9.95
+87.45%
5.31
Net Debt
743.96
—
—
—
Capital Lease Obligations
148.01
+1204.63%
11.35
+14.04%
9.95
+87.45%
5.31
Net Tangible Assets
66.49
-79.26%
320.58
+49.40%
214.57
+19.86%
179.02
Tangible Book Value
66.49
-79.26%
320.58
+49.40%
214.57
+19.86%
179.02
Available For Sale Securities
351.26
—
—
—
Investmentin Financial Assets
351.26
0.00
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
300.01
+19.48%
251.08
+241.69%
73.48
+376.97%
-26.53
Cash Flow From Continuing Operating Activities
300.01
+19.48%
251.08
+241.69%
73.48
+376.97%
-26.53
Net Income From Continuing Operations
128.37
+1.85%
126.04
+635.28%
-23.55
+64.15%
-65.68
Depreciation Amortization Depletion
54.50
+218.95%
17.09
+79.59%
9.52
+27.31%
7.47
Depreciation And Amortization
54.50
+218.95%
17.09
+79.59%
9.52
+27.31%
7.47
Other Non Cash Items
29.95
+931.86%
2.90
-50.65%
5.88
+148.02%
2.37
Stock Based Compensation
135.24
+46.49%
92.32
+39.71%
66.08
+54.33%
42.82
Asset Impairment Charge
0.53
+365.79%
0.11
-73.43%
0.43
-61.93%
1.13
Deferred Tax
-12.96
+78.98%
-61.65
-474123.08%
-0.01
+97.81%
-0.59
Deferred Income Tax
-12.96
+78.98%
-61.65
-474123.08%
-0.01
+97.81%
-0.59
Operating Gains Losses
—
—
—
—
Gain Loss On Investment Securities
—
—
—
—
Unrealized Gain Loss On Investment Securities
-4.44
0.00
0.00
—
Change In Working Capital
-29.16
-137.09%
78.62
+277.61%
20.82
+246.68%
-14.20
Change In Inventory
-13.72
+67.02%
-41.61
-4513.30%
-0.90
+88.73%
-8.00
Change In Prepaid Assets
-51.86
-446.20%
-9.49
-48.46%
-6.39
-0.95%
-6.33
Change In Payables And Accrued Expense
-12.76
-119.72%
64.68
+171.20%
23.85
+591.65%
3.45
Change In Accrued Expense
-43.05
-280.96%
23.79
+43.98%
16.52
+1717.82%
0.91
Change In Payable
30.30
-25.90%
40.88
+458.23%
7.32
+188.46%
2.54
Change In Account Payable
30.30
-30.69%
43.71
+496.81%
7.32
-42.43%
12.72
Change In Other Working Capital
51.60
-23.61%
67.55
+978.93%
6.26
+464.86%
-1.72
Change In Other Current Assets
-0.52
-825.00%
-0.06
+3.45%
-0.06
-441.18%
0.02
Change In Other Current Liabilities
-1.91
+21.69%
-2.44
-26.38%
-1.93
-20.44%
-1.60
Investing Cash Flow
-1,024.96
-5280.92%
-19.05
-57.34%
-12.11
-134.89%
34.70
Cash Flow From Continuing Investing Activities
-1,024.96
-5280.92%
-19.05
-57.34%
-12.11
-134.89%
34.70
Net PPE Purchase And Sale
-226.04
-442.66%
-41.66
-141.90%
-17.22
-534.49%
-2.71
Purchase Of PPE
-226.04
-442.66%
-41.66
-141.90%
-17.22
-534.49%
-2.71
Capital Expenditure
-242.59
-359.89%
-52.75
-99.12%
-26.49
-265.56%
-7.25
Net Investment Purchase And Sale
-637.14
-1397.61%
49.10
+241.31%
14.39
-66.07%
42.41
Purchase Of Investment
-745.84
-364.51%
-160.56
-2.11%
-157.24
+16.23%
-187.70
Sale Of Investment
108.70
-48.16%
209.66
+22.16%
171.62
-25.41%
230.10
Net Business Purchase And Sale
-145.23
-843.09%
-15.40
0.00
+100.00%
-0.46
Purchase Of Business
-145.23
-843.09%
-15.40
0.00
+100.00%
-0.46
Net Intangibles Purchase And Sale
-16.55
-49.13%
-11.10
-19.66%
-9.27
-104.54%
-4.53
Purchase Of Intangibles
-16.55
-49.13%
-11.10
-19.66%
-9.27
-104.54%
-4.53
Financing Cash Flow
729.62
+776.55%
-107.84
-839.83%
-11.47
+65.36%
-33.13
Cash Flow From Continuing Financing Activities
729.62
+776.55%
-107.84
-839.83%
-11.47
+65.36%
-33.13
Net Issuance Payments Of Debt
970.00
0.00
0.00
0.00
Issuance Of Debt
970.00
0.00
0.00
0.00
Repayment Of Debt
—
—
—
0.00
Long Term Debt Issuance
970.00
0.00
0.00
0.00
Long Term Debt Payments
—
—
—
0.00
Net Long Term Debt Issuance
970.00
0.00
0.00
0.00
Net Common Stock Issuance
-89.96
-8.33%
-83.04
-4054.03%
-2.00
0.00
Common Stock Payments
-89.96
-8.33%
-83.04
-4054.03%
-2.00
0.00
Repurchase Of Capital Stock
-89.96
-8.33%
-83.04
-4054.03%
-2.00
0.00
Proceeds From Stock Option Exercised
17.47
-43.43%
30.89
+568.51%
4.62
+34.93%
3.42
Net Other Financing Charges
-167.89
-201.47%
-55.69
-295.08%
-14.10
+61.43%
-36.55
Changes In Cash
4.67
-96.24%
124.19
+148.87%
49.90
+299.94%
-24.96
Effect Of Exchange Rate Changes
2.51
+1028.89%
-0.27
-2354.55%
-0.01
+79.25%
-0.05
Beginning Cash Position
221.44
+127.07%
97.52
+104.75%
47.63
-34.43%
72.64
End Cash Position
228.62
+3.24%
221.44
+127.07%
97.52
+104.75%
47.63
Free Cash Flow
57.41
-71.05%
198.33
+322.07%
46.99
+239.12%
-33.78
Interest Paid Supplemental Data
—
—
—
0.00
Income Tax Paid Supplemental Data
23.16
+192.60%
7.92
+613.80%
1.11
+74.37%
0.64
Amortization Of Securities
-2.03
+53.34%
-4.36
+23.41%
-5.69
-3994.52%
0.15
Common Stock Issuance
—
—
0.00
0.00
Issuance Of Capital Stock
—
—
0.00
0.00
Net Preferred Stock Issuance
—
—
—
0.00
Preferred Stock Issuance
—
—
—
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category